| Recruiting | Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 NCT07479745 | Grünenthal GmbH | Phase 1 |
| Completed | A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men NCT07015918 | Pfizer | Phase 1 |
| Unknown | A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects NCT06159101 | Shanghai Henlius Biotech | Phase 1 |
| Completed | A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male NCT05981963 | Bristol-Myers Squibb | Phase 1 |
| Completed | AME Study of [14C]-PC14586 in Healthy Male Participants NCT05523687 | PMV Pharmaceuticals, Inc | Phase 1 |
| Completed | Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participa NCT05475834 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | The Effects of Daily Supplementation of Nutriose® on the Fecal Microbiota in Volunteers. NCT05105425 | Roquette Freres | N/A |
| Unknown | The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028 NCT04808648 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 |
| Completed | Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects NCT04534582 | Shanghai Henlius Biotech | Phase 1 |
| Unknown | The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus NCT04633733 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Unknown | Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [1 NCT04476394 | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 |
| Unknown | Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth NCT04444011 | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 |
| Completed | Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects NCT04411550 | Shanghai Henlius Biotech | Phase 1 |
| Unknown | Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs NCT04490434 | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| Completed | The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers NCT04810533 | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 |
| Completed | An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Followin NCT04086719 | Bristol-Myers Squibb | Phase 1 |
| Terminated | Compare Pharmacokinetic, Safety, Tolerability and Immunogenicity of HLX12 and Ramucirumab in Healthy Male Adul NCT03863587 | Shanghai Henlius Biotech | Phase 1 |
| Completed | Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Vo NCT03941340 | Allist Pharmaceuticals, Inc. | Phase 1 |
| Completed | Study to Determine the Effect of Food on the Blood Levels of AST2818 Following Single Oral Doses in Healthy Ma NCT03926182 | Allist Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations NCT03810664 | OPKO Health, Inc. | Phase 1 |
| Completed | Bioavailability of Pea Protein in Young and Old Volunteers NCT06381869 | Roquette Freres | N/A |
| Completed | D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562 NCT03686501 | Invicro | EARLY_Phase 1 |
| Completed | Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802 NCT03532854 | LG Chem | Phase 1 |
| Unknown | A Phase 1 Study of Tegoprazan on Healthy Male Volunteers NCT03530228 | HK inno.N Corporation | Phase 1 |
| Completed | A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UC NCT03464227 | UCB Biopharma S.P.R.L. | Phase 1 |
| Completed | Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN11 NCT03468725 | Xenon Pharmaceuticals Inc. | Phase 1 |
| Completed | BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in NCT03355014 | LG Chem | Phase 1 |
| Completed | A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers NCT03378284 | HK inno.N Corporation | Phase 1 |
| Completed | Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501 NCT03089112 | Hanmi Pharmaceutical Company Limited | Phase 1 |
| Completed | A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese NCT03086382 | UCB Biopharma S.P.R.L. | Phase 1 |
| Completed | A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects NCT03014895 | EA Pharma Co., Ltd. | EARLY_Phase 1 |
| Completed | Food Effect Study of Anaprazole in Healthy Chinese Subjects NCT04463173 | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 |
| Terminated | First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375 NCT01965301 | Bioprojet | Phase 1 |
| Completed | The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca NCT02250976 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects NCT04467060 | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 |
| Completed | Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules NCT01948011 | Bioprojet | Phase 1 |
| Completed | The Influence of Oxytocin on the Processing of Social Contact NCT01939639 | University Hospital, Bonn | Phase 1 |
| Completed | Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin NCT01767610 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects (Study E6011-J081-001) NCT01731275 | Eisai Co., Ltd. | Phase 1 |
| Completed | The Pharmacokinetic Interaction Between Celecoxib and Rebamipide NCT01549743 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | A Study of LY2784544 in Healthy Male Subjects NCT01577355 | Eli Lilly and Company | Phase 1 |
| Completed | ITF2984 Repeated Doses Study in Healthy Volunteers NCT01871844 | Italfarmaco | Phase 1 |
| Completed | Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making NCT01607970 | University Hospital, Bonn | Phase 1 |
| Completed | Oxytocin and Social Cognition NCT01606462 | University Hospital, Bonn | Phase 1 |
| Completed | Effects of Lacosamide on Human Motor Cortex Excitability: a Transcranial Magnetic Stimulation Study NCT01382017 | University of Kiel | N/A |
| Completed | CKD-828 Drug Interaction Study (Telmisartan) NCT01356017 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | CKD-828 Drug Interaction Study (S-amlodipine) NCT01356043 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers NCT01342055 | LG Life Sciences | Phase 1 |
| Completed | A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate NCT01290900 | Pfizer | Phase 1 |
| Completed | Pharmacokinetic Drug Interaction Study in Healthy Male Subjects NCT01426906 | LG Life Sciences | Phase 1 |
| Completed | Drug Interaction Between CKD-501 and Metformin NCT01005160 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741 NCT00817544 | Orion Corporation, Orion Pharma | Phase 1 |
| Completed | Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX NCT01367483 | Bausch Health Americas, Inc. | Phase 1 |
| Completed | Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Mu NCT00297960 | Medical University of Vienna | Phase 4 |